David R Liu

36PUBLICATIONS
279CO-AUTHORS
Gene and molecular therapyMolecular targetsPredictive and prognostic markersInnate immunityCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|May 25, 2026
Genomic, Clinical, and Spatial Predictors of Durable Response to BRAF/MEK Inhibition in BRAF-Mutant Melanoma.

|Feb 18, 2026
Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance.

Yubao Wang, Cherubin Manokaran, Yutian Zou

|Dec 31, 2025
Mechanisms of tumor persistence in metastatic melanoma following successful immunotherapy.

Yingxiao Shi, Zoltan Maliga, Tuulia Vallius

|Sep 02, 2025
Defensive tolerance drives the reprogramming and dysfunction of infiltrating pathogenic B cells assuring the maintenance of tolerance.

Koki Hayashi, Takahiro Yokose, Jenna Lancey

|Sep 01, 2025
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma.

Jiekun Yang, Cassia Wang, Doris Fu

|Jul 22, 2025
Specific oncogene activation of the cell of origin in mucosal melanoma.

Swathy Babu, Jiajia Chen, Chloé S Baron

Pageof 6

Frequent Collaborators

7 joint publications

Eliezer Van Allen

6 joint publications

Giuseppe Tarantino

5 joint publications

Genevieve M Boland

4 joint publications

Lynette M Sholl